TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675 | +57.3% | 24,476 | +41.9% | 0.00% | 0.0% |
| Q2 2023 | $429 | +65.6% | 17,253 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $259 | +27.0% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $204 | -99.8% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +39.7% | 17,253 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -55.5% | 17,253 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $164,000 | -50.0% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | -42.9% | 17,253 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $574,000 | -14.2% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $669,000 | -19.6% | 17,253 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $832,000 | -7.3% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $898,000 | +94.4% | 17,253 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $462,000 | +37.5% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $336,000 | +93.1% | 17,253 | -2.4% | 0.00% | +100.0% |
| Q1 2020 | $174,000 | +17.6% | 17,680 | +32.4% | 0.00% | 0.0% |
| Q4 2019 | $148,000 | +97.3% | 13,349 | 0.0% | 0.00% | – |
| Q3 2019 | $75,000 | -34.8% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $115,000 | +7.5% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $107,000 | +94.5% | 13,349 | 0.0% | 0.00% | – |
| Q4 2018 | $55,000 | -26.7% | 13,349 | 0.0% | 0.00% | – |
| Q3 2018 | $75,000 | -57.4% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $176,000 | -7.4% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $190,000 | +74.3% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $109,000 | -31.0% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $158,000 | +17.9% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $134,000 | -14.1% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $156,000 | +151.6% | 13,349 | 0.0% | 0.00% | – |
| Q4 2016 | $62,000 | -39.8% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $103,000 | +27.2% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $81,000 | -28.9% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $114,000 | +5.6% | 13,349 | +46.9% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +17.4% | 9,090 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $92,000 | -39.1% | 9,090 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $151,000 | – | 9,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |